Replying to:
Shripad Banavali from the Department of Medical and Pediatric Oncology, Tata Memorial Centre, in India; Eddy Pasquier from the Aix Marseille Université, Inserm, CRO2 UMR_S 91, Marseille France and Nicolas André from the Service d’Hématologie & Oncologie Pédiatrique, AP-HM in Marseille France and all members of MGHI have just published a case report entitled "Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic (...)